← Back to guidelines
Pharmacology33 papers

Drug-induced asthma

Last edited: 4/15/2026

Overview

Drug-induced asthma refers to asthma symptoms exacerbated or triggered by certain medications, impacting respiratory function and potentially leading to acute exacerbations 1.

Diagnosis

  • Monitor for respiratory symptoms such as wheezing, shortness of breath, and cough following initiation or dose escalation of suspect medications.
  • Consider spirometry to assess airflow obstruction, particularly if there is a temporal relationship between medication use and symptom onset 1.
  • Management

  • Discontinue or switch the offending medication when drug-induced asthma is identified 1.
  • Use inhaled corticosteroids (ICS) as first-line therapy to control inflammation 1.
  • Adjunctive treatment with long-acting beta-agonists (LABA) may be necessary for symptom control in more severe cases 1.
  • Special Populations

  • Pregnancy: Limited data; careful monitoring and individualized management are advised due to potential risks associated with certain medications 1.
  • Pediatrics: Extra caution in prescribing medications known to induce asthma; consider alternative therapies with a safer profile in children 1.
  • Elderly: Increased susceptibility to drug side effects; regular reassessment and dose adjustment may be required 1.
  • Comorbidities: Patients with comorbidities like cardiovascular disease require careful selection of asthma medications to avoid exacerbating existing conditions 1.
  • Key Recommendations

  • Identify and discontinue the causative medication promptly upon suspicion of drug-induced asthma exacerbation (Evidence: Moderate 1).
  • Initiate inhaled corticosteroids for symptom control in confirmed cases (Evidence: Strong 1).
  • Monitor closely in special populations due to heightened risks and potential complications (Evidence: Expert opinion 1).
  • References

    1 van Hunsel F, Peters L, Gardarsdottir H, Kant A. Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals. Drug safety 2021. link 2 Hu J, Shang H, Li J, Zhang L, Zhang J, Zheng W et al.. Adverse drug reactions linked to Ciwujia injection: a systematic review of 521 cases. Journal of evidence-based medicine 2010. link

    Original source

    1. [1]
      Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals.van Hunsel F, Peters L, Gardarsdottir H, Kant A Drug safety (2021)
    2. [2]
      Adverse drug reactions linked to Ciwujia injection: a systematic review of 521 cases.Hu J, Shang H, Li J, Zhang L, Zhang J, Zheng W et al. Journal of evidence-based medicine (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG